| NKTR Snapshot | |
|---|---|
| Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India. | |
| VALUATION DATA | |
| Market Capitalization | $260,737,000 | Price to Sales | 3.00 |
| Earnings per Share | $-1.4500 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $1.3200 |
| 52 Week High | $3.402 |
| 52 Week Low | $2.341 |
| 50-Day Moving Average | $1.34 |
| 200-Day Moving Average | $-0.497 |
| All data are from Alpha Vantage as of today. For more infomation on NKTR see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search